The U.S.-based National Emerging Infectious Diseases Laboratories says the new treatment uses RNA, a type of genetic material similar to DNA, which prevents the Ebola virus from reproducing by targeting three viral proteins.
The Boston University laboratory says more research is needed to determine if the treatment is safe for humans.
Ebola kills about 90 percent of people who become infected.
It causes fever, diarrhea, vomiting and sometimes hemorrhaging from bodily orifices.
Photo: Peace Corp